𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis

✍ Scribed by Elenir B.C. Avritscher; Catherine D. Cooksley; Linda S. Elting

Book ID
117823359
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
106 KB
Volume
20
Category
Article
ISSN
0749-2081

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical practice guidelines for the pre
Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis
✍ Edward B. Rubenstein; Douglas E. Peterson; Mark Schubert; Dorothy Keefe; Deborah πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 2 views

## BACKGROUND. Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherap

Perspectives on cancer therapy-induced m
Perspectives on cancer therapy-induced mucosal injury : Pathogenesis, measurement, epidemiology, and consequences for patients
✍ Stephen T. Sonis; Linda S. Elting; Dorothy Keefe; Douglas E. Peterson; Mark Schu πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 409 KB

Dr. Sonis has served as a consultant for Biomodels and Affiliates, LLC (Wellesley, MA). Dr. Elting has received speaker's honoraria from McNeill Pharmaceuticals and Endo Pharmaceuticals (Chadds Ford, PA). Dr. Keefe has received research funding and speaker's honoraria from Amgen. Dr. Peterson has se